Esophageal Carcinoma Following Bariatric Procedures by Allen, Jeff W. et al.
Esophageal Carcinoma Following
Bariatric Procedures
Jeff W. Allen, MD, Matthew F. Leeman, BSc, J. David Richardson, MD
ABSTRACT
Background: The long-term success of bariatric opera-
tions for weight reduction has been well documented, but
their potential effects on the risk of esophageal cancer
have not been evaluated.
Methods: We performed operations on 3 patients for
esophageal cancer following bariatric operations: 2 had
Roux-en-Y gastric bypass, and 1 underwent vertical
banded gastroplasty. All of these patients had adenocar-
cinoma at the gastroesophageal junction; 1 involved the
entire intrathoracic esophagus.
Results: The intervals between the weight-loss operations
and cancer diagnoses were 21, 16, and 14 years. All 3
patients had symptoms of reflux for many years before
dysphagia developed and cancer was diagnosed. We per-
formed a limited esophagogastrectomy, a classic Ivor-
Lewis procedure, and a total esophagectomy with jejunal
free-tissue transfer from stomach to cervical esophagus.
Two patients had positive lymph nodes. One patient is
alive at 6 years; 2 died at 13 and 15 months after under-
going operation for recurrent cancer.
Conclusion: The effect of bariatric operations on gastro-
esophageal reflux is not known, although gastric bypass
has been advocated as the “ultimate antireflux proce-
dure.” The presence of esophageal cancer in these 3
patients years after the weight loss operation is worri-
some. We believe that patients who develop new symp-
toms should have endoscopic evaluation and that epide-
miologic studies on the incidence of esophageal cancer
occurring years after bariatric operation should be per-
formed.
Key Words: Bariatric surgery, Morbid obesity, Esopha-
geal adenocarcinoma.
INTRODUCTION
Morbid obesity [body mass index (BMI)  40 kg/m
2]i s
reaching epidemic proportions in the United States.1,2
Surgical treatment of obesity, which began in the 1950s
with the jejunoileal bypass, is rapidly evolving. A growing
body of evidence supports the safety and efficacy of
bariatric operations.3–8 Modern weight-loss operations in-
volve some manipulation of the stomach,9 thereby alter-
ing the structure and function of the upper gastrointestinal
tract. Adenocarcinoma of the esophagus, like morbid obe-
sity, also has increased at an alarming rate in recent
years.10,11 No association between weight-loss operations
on the stomach and gastroesophageal cancer has been
previously reported. We present herein 3 cases of esoph-
ageal adenocarcinoma that occurred after bariatric proce-
dures and highlight the need for formal epidemiologic
testing and further investigation of this phenomenon.
CASE REPORTS
Patient 1
A 54-year-old morbidly obese man underwent gastric by-
pass with stapled division of the stomach and Roux-en-Y
gastrojejunostomy 21 years before he developed cancer.
He experienced persistent symptoms of regurgitation, par-
ticularly after overeating. Upper endoscopy (EGD) dis-
closed a columnar-lined esophagus without atypia 5 years
before his cancer was diagnosed. Surveillance endoscopy
was performed on 2 occasions. Atypia had been noted 26
months earlier. The patient failed to have a follow-up
EGD, but 3 months prior to presentation, he developed
dysphagia. Adenocarcinoma was confirmed by EGD in
biopsies from the distal, mid- and proximal esophagus.
Computed tomography (CT) demonstrated a thickened
esophagus with no tumor outside the chest, in the liver, or
the abdomen, and no evidence of nodal involvement.
A total esophagectomy was performed with en bloc re-
section of the upper stomach through a midline incision
and right thoracotomy. A jejunal free-tissue transfer was
used for alimentary tract reconstruction, with an anasto-
mosis between the cervical esophagus and jejunal graft
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CASE REPORTproximally and the graft and stomach remnant distally. A
tube jejunostomy was placed as well.
The specimen contained a long segment of adenocarci-
noma from the gastroesophageal junction to the proximal
thoracic esophagus. The patient recovered after a lengthy
operative procedure and was able to eat solid food, but he
required supplemental tube feedings to maintain ade-
quate caloric intake. Cancer recurred at 8 months
postesophagectomy, and he died 13 months after his op-
eration.
Patient 2
A 31-year-old woman underwent a jejunoileal bypass in
1973 for morbid obesity. Eight years later, she had lost 64
kg of weight but was disabled by arthritis, and results of
her liver function tests were abnormal. Her jejunoileal
bypass was surgically reversed, resulting in prompt
weight gain and improvement of her symptoms. Sixteen
months later, an incisional hernia was repaired and a
vertical banded gastroplasty (VBG) performed. She devel-
oped reflux symptoms that were treated with histamine
receptor blocking agents. In 1999, at age 57, the patient’s
persistent vomiting and dysphagia necessitated perfor-
mance of an upper gastrointestinal series, which disclosed
a severe stenotic lesion at the gastroesophageal junction.
An EGD showed an ulcerating lesion containing signet
ring type adenocarcinoma.
At operation, the patient’s cancer was found to extend into
the lesser curvature of the stomach, which prompted a
total gastrectomy. A Roux-en-Y esophagojejunostomy was
performed. The patient died of recurrent intraabdominal
cancer 15 months after the operation.
Patient 3
A 36-year-old man underwent a Roux-en-Y gastric bypass
in 1982. He lost 80% of excess body weight, but slowly
regained weight after about 10 years. Fourteen years after
his gastric bypass, he developed dysphagia that was ini-
tially attributed to a stricture. An EGD showed a lesion at
the gastroesophageal junction. Biopsy results were posi-
tive for adenocarcinoma. An esophagogastrectomy was
performed through a combined abdominal and right tho-
racotomy. A gastric tube was created from the stomach,
despite the previous operation on the fundus. The patient
had a small primary cancer that did not invade the mus-
cularis. The postoperative course was uneventful, and the
patient remains free of recurrent cancer 6 years after his
operation.
DISCUSSION
The association between bariatric procedures and subse-
quent development of gastroesophageal adenocarcinoma
may be coincidental. However, these cases suggest a re-
lationship between gastric weight-loss operations and the
development of adenocarcinoma of the gastroesophageal
junction. Although the pathogenesis of esophageal ade-
nocarcinoma is still not fully understood,12 these cases
suggest that there may be other, unidentified etiological
agents or pathophysiological processes involved.
It is possible that the gastric pouch, which represents the
terminal portion of the functional stomach and is common
to both gastroplasty and gastric bypass, increases expo-
sure of the vulnerable lower esophagus to carcinogens
due to their proximity. For example, compounds normally
present in the gastric antrum are unavoidably placed
closer to the esophagus as a result of these procedures.
The link between gastric acid reflux and the development
of Barrett’s metaplasia, esophageal dysplasia, and adeno-
carcinoma is well established. The normal transit of gastric
acid, secreted within the gastric pouch, is almost certainly
prolonged, therefore increasing the severity and duration
of acid reflux. Motility changes that can occur after the
gastric manipulation required in these operations in-
creases acid exposure.
Operations that alter the “native” contents of the gastro-
intestinal tract and predisposes it to cancer is not a new
concept. There have been reports of cancer developing in
the “neo-esophagus,” following colonic interposition13
and Collis gastroplasty.14 Furthermore, adenocarcinoma
of the jejunal component of Roux loop has also been
described.15
The role of duodenogastroesophageal reflux in esopha-
geal adenocarcinoma development has been an issue of
recent debate.16–18 However, gastric bypass, as performed
in 2 of our patients, has been advocated as the ultimate
antireflux procedure17 and should, by definition, eliminate
duodenogastroesophageal reflux. It has recently been
suggested that a duodenal diversion (Roux-en-Y) proce-
dure is superior to simple fundoplication in treating pa-
tients with Barrett’s esophagus.19 Furthermore, several in-
vestigators have found no relationship between previous
gastric surgery (as a model of duodenogastroesophageal
reflux) and esophageal adenocarcinoma.20,21
Much evidence exists linking adenocarcinoma of the
esophagus and obesity.10,22–28 It is entirely possible that
these patients were predisposed to esophageal cancer
because of their obesity and not the bariatric procedure,
JSLS (2004)8:372–375 373although each achieved significant weight loss following
surgery. On the other hand, it is imperative that formal
epidemiological research either confirm or refute this wor-
risome possibility. Since the cancers described above oc-
curred many years after the bariatric operations, the orig-
inal surgeon may no longer be involved in the care of
such patients.
Regardless of the possible link between bariatric proce-
dures and subsequent cancer development, clinicians
must be diligent in their investigation of new symptoms
that could be caused by cancer. Because many of these
patients have ongoing regurgitation associated with over-
eating, the recognition of relevant symptoms may be
problematic.
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